Sonnet BioTherapeutic News

Sonnet BioTherapeutic | S-1: General form for registration of securities under the Securities Act of 1933

May 3 08:36 ET

Sonnet BioTherapeutic | 8-K: Current report

May 3 08:06 ET

Sonnet BioTherapeutic | 8-K: Current report

Mar 11 07:31 ET

Sonnet BioTherapeutic | 8-K: Current report

Mar 6 16:28 ET

Sonnet BioTherapeutic | 8-K: Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update

Feb 14 07:37 ET

Sonnet BioTherapeutic | 8-K: Current report

Feb 1 16:23 ET

Sonnet BioTherapeutic | 8-K: Current report

Jan 29 16:21 ET

Sonnet BioTherapeutic | 8-K: Current report

Dec 27, 2023 00:00 ET

Sonnet BioTherapeutic | S-3: Registration statement for specified transactions by certain issuers

Dec 22, 2023 16:31 ET

Sonnet BioTherapeutic | 8-K: Current report

Dec 15, 2023 16:30 ET

Sonnet BioTherapeutic | 8-K: Current report

Dec 14, 2023 17:03 ET

Sonnet BioTherapeutic | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Oct 19, 2023 17:14 ET

Sonnet BioTherapeutic | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Oct 4, 2023 16:18 ET

Sonnet BioTherapeutic | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Sep 28, 2023 08:48 ET

Sonnet BioTherapeutic | S-1: General form for registration of securities under the Securities Act of 1933

Sep 19, 2023 16:30 ET

Sonnet BioTherapeutic | 8-K: Current report

Sep 19, 2023 08:30 ET

Sonnet BioTherapeutic | 8-K: Current report

Sep 1, 2023 08:30 ET

Sonnet BioTherapeutic | 8-K: Current report

Aug 31, 2023 17:18 ET

Sonnet BioTherapeutic | 8-K: Current report

Aug 22, 2023 08:30 ET

Sonnet BioTherapeutic | DEFA14A: Others

Aug 22, 2023 08:30 ET